Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/ac101962x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Commentary: Effects of occlusion pressure on hemodynamic responses recorded by near-infrared spectroscopy across two visits.
Front Physiol
November 2024
Graduate Program in Health Sciences, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.
Esophageal oxyhemoglobin saturation as a resuscitative metric in hemorrhagic shock.
Trauma Surg Acute Care Open
August 2024
Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
Background: Mixed venous saturation (SvO2) is considered the gold standard to assess the adequacy of tissue oxygen delivery (DO2) in shock states. However, SvO2 monitoring is challenging as it requires an invasive catheter and frequent blood sampling. Non-invasive methods, including near-infrared spectroscopy, have demonstrated low sensitivity to tissue dysoxia.
View Article and Find Full Text PDFNear-infrared fluorescence imaging plus indocyanine green fluorescence in patients undergoing a total thyroidectomy and central neck lymph node dissection: is it worth it?
Gland Surg
August 2024
Department of Surgery, University of California Davis Medical Center, Sacramento, CA, USA.
Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial.
JAMA Cardiol
December 2024
Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
Importance: Previous studies investigated atherosclerotic changes induced by lipid-lowering therapy in extensive coronary segments irrespective of baseline disease burden (a vessel-level approach).
Objective: To investigate the effects of lipid-lowering therapy on coronary lesions with advanced atherosclerotic plaque features and presumably higher risk for future events.
Design, Setting, And Participants: The PACMAN-AMI randomized clinical trial (enrollment: May 2017 to October 2020; final follow-up: October 2021) randomized patients with acute myocardial infarction to receive alirocumab or placebo in addition to high-intensity statin therapy.
NIRS during Organ Donation in Brain-dead Donors: Comment.
Anesthesiology
October 2024
General Hospital Vienna, Medical University of Vienna, Vienna, Austria (M.D.).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!